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Rocky mountain spotted fever is a severe disease caused by 
Rickettsia rickettsii that frequently causes the death of the patients. 
As there are not effective vaccines for this disease, we employed 
reverse vaccinology to find epitope candidates useful for vaccine 
development. To apply this bioinformatics, we used the following 
online software: ProPred1, RANKPEP, and HLA binding, to 
evaluate 143 amino acid sequences in the genome of Rickettsia 
rickettsii (NC_009882 Sheila Smith). This strategy allowed us to 
identify 19 epitope sequences with affinity to HLA I alleles: A0201, 
A24; HLA-B: B3501, B3901.  
Keywords: Epitope prediction, Rocky mountain spotted fever, 
Vaccine 
Introduction 
Rickettsia rickettsii (R. rickettsii) is a gram-negative 
bacteria that infects human hosts following its 
inoculation through the bite of arthropod vectors, 
producing a disease characterized byendothelial 
dysfunction, vasculitis, coagulopathy, myocarditis, and 
organic failure in severe cases
1
. Several efforts have been 
made to reduce mortality of rickettsiosis through 
vaccination using whole killed and attenuated bacteria, 
but also using recombinant proteins composed of single 
or multiple epitopes; however, even than those have 
different degrees of success we still lack a vaccine for 
humans
2
. It is known the critical role of cellular response 
by Th1 and T CD8+ cell in rickettsiosis which has been 
demonstrated through diverse epitopes however, 
experimental and analysis procedures to identify new 
epitope targets are expensive and time consuming; in 
contrast with its prediction through in silico assays like 
reverse vaccinology
2,3
. This approach could predict 
several candidate proteins through mathematical 
simulation of host-pathogen interaction models like 
Rickettsia prowazekii, with different degrees of 
success
4,5
. In this study, we did the first complete 
scanning of the whole genome of R. rickettsii 
(NC_009882. Sheila Smith) to identify epitope sequences 
related to the cellular response by CD8
+
 lymphocytes, that 
could be used for vaccine development, considering its 
binding capacity and affinity with the most frequent 
HLA alleles, and its homology with proteins from the 
bacteria but not from its human host. 
 
Materials and Methods 
Individuals within the same species can express 
different alleles from HLA I capable to recognize and 
bind different epitopes
6
. There is a direct association 
between the immunogenicity and the affinity of an 
HLA peptide complex, however, its stability is 
equally important, as a low dissociation velocity 
grants enough stability for the complex in the cell 
surface to promote adequate interactions with specific 
T lymphocytes
7
. Considering this, the first step was to 
evaluate1343 sequences to predict epitopes that could 
bind to the most frequently expressed molecules of 
HLA I worldwide (HLA A0201, A24, B3501, B3901) 
using ProPred1 (http://www.imtech.res.in/raghava/ 
propred1/) and Rankpep (http://imed.med.ucm.es/ 
Tools/rankpep.html). Additionally, the average time 
of dissociation in min at 37C for each epitope was 
obtained with the HLA Peptide Binding Prediction 
Tool (http://www-bimas.cit.nih.gov/molbio/hla_bind/). 
Results are shown in (Table 1).  
 
Results 
We obtained 19 sequences with at least two 
promiscuous epitopes that could bind to at least two 
HLA alleles. Identity analyses employing the BLAST 
tool did not found an identity with human sequences 
avoiding the possibility of autoimmunity, but identified 
up to 98% identity with amino acid sequences from 
other Rickettsia species (Table 1). Among these, outer 
membrane proteins (Omps), particularly OmpA and 
OmpB, have been tested with promising results, being 
able to elicit humoral and cellular immune responses 
which interestingly can provide cross reactivity against 














Table 1 — In silico analysis of the chosen amino acid from Rickettsia rickettsii 
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In our analysis we found several small regions 
potentially immunogenic among different Omps, that 
could be analyzed as sub-unit vaccines looking for 
stronger and oriented responses as it has been done in 
other studies
8-11
. Reports related to OmpA have used 
epitopes from the middle and c-terminal portions of 
the protein, whereas our study suggest that there are 
several epitopes within the first 1500 amino acids 
which could be potential immunogenic candidates
11,12
. 
This is also the case for the identified epitopes  
in OmpB, which are contained within the first  




1600 amino acids of the protein; a region that 
experimentally has shown its immunogenic and 
protective potential, but has not been deeply evaluated 
in further studies
8-11
. We also identified peptides in 9 
proteins related to metabolism, which has not been 
experimentally analyzed in terms of immunogenicity 
and could be interesting for future approaches.Further 
analysis of the sequences using BLAST allowed to 
assign name and function for several sequences 
however, 5 of them remained hypothetical. Interestingly, 
we found that the sequence of the hypothetical  
protein A1G_00830 contains the motifs of VirB6, a 
component of the type IV secretion system (TIVSS), a 
protein complex implied in the exchange of genetic 
material that, due to its transmembrane localization, is 
an interesting target for neutralizing and protective 
immune responses particularly linked by recognition 
between T CD4
+
 and  cells, as it has been studied  
in Anaplasma marginale
13,14
. VirB6-like protein are 
codified by five tandemly arrayed genes in Rickettsia 
species (rvhB6a-c), that shows highly divergent and 
surface exposed N and C sequences flanking the 
VirB6/TrbL domain
13
. The impact of such potential 
variability in the structure of TIVSS in the pathogenicity 
and immunogenicity of rickettsial pathogens remains to 
be studied, but suggest that could be interesting targets 
for diagnosis or vaccine development. 
As shown by data obtained in this work, reverse 
vaccinology is a promising strategy that allowed to 
find several peptides that could be evaluated in vaccine 
trials, considering not only its immunogenic potential 
in terms of the cellular response that could elicit but 
also, its binding strength and affinity for the more 
abundantly HLA molecules expressed worldwide. 
 
Conclusion 
In the present study it was possible to predict new 
high potential immunogenic sequences for the 
development of a candidate vaccine, from the complete 
genome of R. rickettsii, through bioinformatic studies of 
reverse vaccinology. The selection of this limited 
number of promising peptides makes their evaluation 
feasible in subsequent in vivo studies with animal 
models to check their immunogenicity and protection. 
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